tetrapentylammonium has been researched along with valinomycin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baio-Larue, C; Feinstein, MB; Flaumenhauft, R; Matthews, E; O'Rourke, F; Soons, K; Watras, J | 1 |
| Leoncini, G; Pascale, R; Signorello, MG | 1 |
2 other study(ies) available for tetrapentylammonium and valinomycin
| Article | Year |
|---|---|
Ca2+ release by inositol 1,4,5-trisphosphate is blocked by the K(+)-channel blockers apamin and tetrapentylammonium ion, and a monoclonal antibody to a 63 kDa membrane protein: reversal of blockade by K+ ionophores nigericin and valinomycin and purificati
Topics: Animals; Antibodies, Monoclonal; Antigens, Surface; Aorta; Apamin; Blood Platelets; Calcium; Humans; Inositol 1,4,5-Trisphosphate; Membrane Proteins; Molecular Weight; Nigericin; Potassium Channel Blockers; Potassium Channels; Quaternary Ammonium Compounds; Swine; Valinomycin | 1994 |
Transport of L-arginine and nitric oxide formation in human platelets.
Topics: Anti-Bacterial Agents; Arginine; Biological Transport; Blood Platelets; Cyclic GMP; Enzyme Inhibitors; Ethylmaleimide; Gramicidin; Humans; Ionophores; Leucine; Membrane Transport Proteins; Nitric Oxide; Quaternary Ammonium Compounds; Sodium; Valinomycin | 2003 |